Digital PCR Market By Technology, By Product Type, By Application, By End User, : Global Opportunity Analysis and Industry Forecast, 2020-2030

Description

List of Tables

The global digital PCR market was valued at $508.8 million in 2020, and is projected to reach $1,305.3 million by 2030, registering a CAGR of 8.6% from 2021 to 2030. Digital polymerase chain reaction (dPCR) is defined as an approach for the detection & quantification of nucleic acids that provides a sensitive and reproducible way to measure the amount of DNA or RNA present in a sample. dPCR exhibits high potential in research (basic research and applied research), clinical diagnostics, forensics, and other similar areas. dPCR systems are useful for copy number variation, rare sequence detection, mutation detection, miRNA analysis, gene expression analysis, and next-generation sequencing sample quantification.

The global digital polymerase chain reaction market is expected to register substantial growth in the near future owing to rise in prevalence of infectious diseases and increase in awareness & acceptance of personalized medicines. For instance, according to World Health Organization (WHO), around 1.5 million people died from tuberculosis in 2020 across the globe. Droplet digital PCR (ddPCR) is one of the analysis tests to detect the presence of mycobacterium tuberculosis. In addition, advancements in the technology in healthcare sector are anticipated to boost the market growth during the forecast period.

However, high cost of dPCR devices and reimbursement issues are the factors anticipated to hamper the market growth during the forecast period. Conversely, surge in funding for R&D activities in medical devices sector is expected to offer remunerative opportunities for market players. The digital polymerase chain reaction market is segmented into technology, product type, application, end user, and region. By technology, the market is categorized into droplet digital PCR (ddPCR), chip based digital PCR, and BEAMing digital PCR.

By product type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others. As per end user, it is differentiated into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations. Region wise, it is analyzed across North America (U.S., Canada, and Mexico) Europe (Germany, France, UK, Italy, Spain, and rest of Europe) Asia-Pacific (Japan, China, Australia, India, South Korea, Taiwan, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players that operate in the global digital polymerase chain reaction market include Avance Biosciences, Bio-Rad Laboratories, Inc., Fluidigm Corporation, JN Medsys, Merck KGaA, PreciGenome LLC, Qiagen N.V, Stilla Technologies, Sysmex Corporation and Thermo Fisher Scientific, Inc.

KEY BENEFITS FOR STAKEHOLDERS

The report provides an in-depth analysis of the global digital PCR market size along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global digital PCR market growth.

Key Market Segments

By BY TECHNOLOGY

Droplet Digital Pcr
Chip Based Digital Pcr
Beaming Digital Pcr

By BY PRODUCT TYPE

igital Pcr Systems
Consumables And Reagents
Software And Services

By BY APPLICATION

Clinical Diagnostics
Forensic And Others
Research

By BY END USER

Pharmaceuticals And Biotechnology Industries
Clinical Diagnostic Laboratories
Universities And Other Organizations

By BY REGION

Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan, Republic Of China
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
Key Market Players
- Avance Biosciences
- Bio-Rad Laboratories, Inc.
- Fluidigm Corporation
- jn medsys
- Merck KGAA
- Precigenome LLC
- QIAGEN N.V
- STILLA TECHNOLOGIES
- sysmex corporation
- Thermo Fisher Scientific, Inc.

Product Code: A00532

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: DIGITAL PCR MARKET, BY TECHNOLOGY

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Droplet Digital Pcr
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Chip Based Digital Pcr
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
4.4 Beaming Digital Pcr
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country

CHAPTER 5: DIGITAL PCR MARKET, BY PRODUCT TYPE

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Digital Pcr Systems
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Consumables And Reagents
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Software And Services
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country

CHAPTER 6: DIGITAL PCR MARKET, BY APPLICATION

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Research
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
6.3 Clinical Diagnostics
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Forensic And Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country

CHAPTER 7: DIGITAL PCR MARKET, BY END USER

7.1 Overview
- 7.1.1 Market size and forecast
7.2 Pharmaceuticals And Biotechnology Industries
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
7.3 Clinical Diagnostic Laboratories
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
7.4 Universities And Other Organizations
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country

CHAPTER 8: DIGITAL PCR MARKET, BY REGION

8.1 Overview
- 8.1.1 Market size and forecast
8.2 Asia-Pacific
- 8.2.1 Key trends and opportunities
- 8.2.2 Asia-Pacific Market size and forecast, by Technology
- 8.2.3 Asia-Pacific Market size and forecast, by Product Type
- 8.2.4 Asia-Pacific Market size and forecast, by Application
- 8.2.5 Asia-Pacific Market size and forecast, by End User
- 8.2.6 Asia-Pacific Market size and forecast, by country
  - 8.2.6.1 Japan
  - 8.2.6.1.1 Market size and forecast, by Technology
  - 8.2.6.1.2 Market size and forecast, by Product Type
  - 8.2.6.1.3 Market size and forecast, by Application
  - 8.2.6.1.4 Market size and forecast, by End User
  - 8.2.6.2 China
  - 8.2.6.2.1 Market size and forecast, by Technology
  - 8.2.6.2.2 Market size and forecast, by Product Type
  - 8.2.6.2.3 Market size and forecast, by Application
  - 8.2.6.2.4 Market size and forecast, by End User
  - 8.2.6.3 Australia
  - 8.2.6.3.1 Market size and forecast, by Technology
  - 8.2.6.3.2 Market size and forecast, by Product Type
  - 8.2.6.3.3 Market size and forecast, by Application
  - 8.2.6.3.4 Market size and forecast, by End User
  - 8.2.6.4 India
  - 8.2.6.4.1 Market size and forecast, by Technology
  - 8.2.6.4.2 Market size and forecast, by Product Type
  - 8.2.6.4.3 Market size and forecast, by Application
  - 8.2.6.4.4 Market size and forecast, by End User
  - 8.2.6.5 South Korea
  - 8.2.6.5.1 Market size and forecast, by Technology
  - 8.2.6.5.2 Market size and forecast, by Product Type
  - 8.2.6.5.3 Market size and forecast, by Application
  - 8.2.6.5.4 Market size and forecast, by End User
  - 8.2.6.6 Taiwan, Republic Of China
  - 8.2.6.6.1 Market size and forecast, by Technology
  - 8.2.6.6.2 Market size and forecast, by Product Type
  - 8.2.6.6.3 Market size and forecast, by Application
  - 8.2.6.6.4 Market size and forecast, by End User
  - 8.2.6.7 Rest of Asia-Pacific
  - 8.2.6.7.1 Market size and forecast, by Technology
  - 8.2.6.7.2 Market size and forecast, by Product Type
  - 8.2.6.7.3 Market size and forecast, by Application
  - 8.2.6.7.4 Market size and forecast, by End User
8.3 LAMEA
- 8.3.1 Key trends and opportunities
- 8.3.2 LAMEA Market size and forecast, by Technology
- 8.3.3 LAMEA Market size and forecast, by Product Type
- 8.3.4 LAMEA Market size and forecast, by Application
- 8.3.5 LAMEA Market size and forecast, by End User
- 8.3.6 LAMEA Market size and forecast, by country
  - 8.3.6.1 Brazil
  - 8.3.6.1.1 Market size and forecast, by Technology
  - 8.3.6.1.2 Market size and forecast, by Product Type
  - 8.3.6.1.3 Market size and forecast, by Application
  - 8.3.6.1.4 Market size and forecast, by End User
  - 8.3.6.2 Saudi Arabia
  - 8.3.6.2.1 Market size and forecast, by Technology
  - 8.3.6.2.2 Market size and forecast, by Product Type
  - 8.3.6.2.3 Market size and forecast, by Application
  - 8.3.6.2.4 Market size and forecast, by End User
  - 8.3.6.3 South Africa
  - 8.3.6.3.1 Market size and forecast, by Technology
  - 8.3.6.3.2 Market size and forecast, by Product Type
  - 8.3.6.3.3 Market size and forecast, by Application
  - 8.3.6.3.4 Market size and forecast, by End User
  - 8.3.6.4 Rest of LAMEA
  - 8.3.6.4.1 Market size and forecast, by Technology
  - 8.3.6.4.2 Market size and forecast, by Product Type
  - 8.3.6.4.3 Market size and forecast, by Application
  - 8.3.6.4.4 Market size and forecast, by End User
8.4 North America
- 8.4.1 Key trends and opportunities
- 8.4.2 North America Market size and forecast, by Technology
- 8.4.3 North America Market size and forecast, by Product Type
- 8.4.4 North America Market size and forecast, by Application
- 8.4.5 North America Market size and forecast, by End User
- 8.4.6 North America Market size and forecast, by country
  - 8.4.6.1 U.S.
  - 8.4.6.1.1 Market size and forecast, by Technology
  - 8.4.6.1.2 Market size and forecast, by Product Type
  - 8.4.6.1.3 Market size and forecast, by Application
  - 8.4.6.1.4 Market size and forecast, by End User
  - 8.4.6.2 Canada
  - 8.4.6.2.1 Market size and forecast, by Technology
  - 8.4.6.2.2 Market size and forecast, by Product Type
  - 8.4.6.2.3 Market size and forecast, by Application
  - 8.4.6.2.4 Market size and forecast, by End User
  - 8.4.6.3 Mexico
  - 8.4.6.3.1 Market size and forecast, by Technology
  - 8.4.6.3.2 Market size and forecast, by Product Type
  - 8.4.6.3.3 Market size and forecast, by Application
  - 8.4.6.3.4 Market size and forecast, by End User
8.5 Europe
- 8.5.1 Key trends and opportunities
- 8.5.2 Europe Market size and forecast, by Technology
- 8.5.3 Europe Market size and forecast, by Product Type
- 8.5.4 Europe Market size and forecast, by Application
- 8.5.5 Europe Market size and forecast, by End User
- 8.5.6 Europe Market size and forecast, by country
  - 8.5.6.1 Germany
  - 8.5.6.1.1 Market size and forecast, by Technology
  - 8.5.6.1.2 Market size and forecast, by Product Type
  - 8.5.6.1.3 Market size and forecast, by Application
  - 8.5.6.1.4 Market size and forecast, by End User
  - 8.5.6.2 France
  - 8.5.6.2.1 Market size and forecast, by Technology
  - 8.5.6.2.2 Market size and forecast, by Product Type
  - 8.5.6.2.3 Market size and forecast, by Application
  - 8.5.6.2.4 Market size and forecast, by End User
  - 8.5.6.3 United Kingdom
  - 8.5.6.3.1 Market size and forecast, by Technology
  - 8.5.6.3.2 Market size and forecast, by Product Type
  - 8.5.6.3.3 Market size and forecast, by Application
  - 8.5.6.3.4 Market size and forecast, by End User
  - 8.5.6.4 Italy
  - 8.5.6.4.1 Market size and forecast, by Technology
  - 8.5.6.4.2 Market size and forecast, by Product Type
  - 8.5.6.4.3 Market size and forecast, by Application
  - 8.5.6.4.4 Market size and forecast, by End User
  - 8.5.6.5 Spain
  - 8.5.6.5.1 Market size and forecast, by Technology
  - 8.5.6.5.2 Market size and forecast, by Product Type
  - 8.5.6.5.3 Market size and forecast, by Application
  - 8.5.6.5.4 Market size and forecast, by End User
  - 8.5.6.6 Rest of Europe
  - 8.5.6.6.1 Market size and forecast, by Technology
  - 8.5.6.6.2 Market size and forecast, by Product Type
  - 8.5.6.6.3 Market size and forecast, by Application
  - 8.5.6.6.4 Market size and forecast, by End User

CHAPTER 9: COMPANY LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments

CHAPTER 10: COMPANY PROFILES

10.1 Avance Biosciences
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
10.2 Bio-Rad Laboratories, Inc.
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
10.3 Fluidigm Corporation
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
10.4 jn medsys
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
10.5 Merck KGAA
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
10.6 Precigenome LLC
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
10.7 QIAGEN N.V
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
10.8 STILLA TECHNOLOGIES
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
10.9 sysmex corporation
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
10.10 Thermo Fisher Scientific, Inc.
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments